Entera Bio (ENTX): Longitude entities report 4.6% ownership, Seven Fleet 4.1%

Rhea-AI Filing Summary

Entera Bio Ltd. has a significant shareholder group led by Longitude Venture Partners V, L.P., which is the record owner of 7,843,138 ordinary shares. Based on 172,251,411 ordinary shares outstanding as of July 28, 2026, the filing reports this position as 4.6% of the class for each Reporting Person.

Longitude Capital Partners V, LLC is the general partner of LVPV, and Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCPV; each may be deemed to share voting and dispositive power over these shares, while disclaiming beneficial ownership except to the extent of pecuniary interest. The filing also notes that Seven Fleet may be deemed to beneficially own 7,053,898 ordinary shares, or 4.1%, under certain policies and procedures, though group status and related beneficial ownership are expressly disclaimed.

Key Figures

LVPV Shares Owned: 7,843,138 ordinary shares Ownership Percentage: 4.6% Shares Outstanding: 172,251,411 ordinary shares +3 more

6 metrics

LVPV Shares Owned 7,843,138 ordinary shares Record ownership by Longitude Venture Partners V, L.P.

Ownership Percentage 4.6% Percentage of Entera Bio ordinary shares reported for each Reporting Person

Shares Outstanding 172,251,411 ordinary shares Outstanding as of July 28, 2026, as provided by the issuer

Seven Fleet Shares 7,053,898 ordinary shares Shares Seven Fleet may be deemed to beneficially own

Seven Fleet Ownership 4.1% Percentage of outstanding ordinary shares potentially beneficially owned by Seven Fleet

Par Value NIS 0.0000769 per share Par value of Entera Bio ordinary shares

Key Terms

beneficial ownership, dispositive power, Schedule 13G, Section 13(d)(3) of the Exchange Act, +2 more

6 terms

beneficial ownership financial

"Except to the extent of such Reporting Person's pecuniary interest therein, each Reporting Person disclaims beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

dispositive power financial

"may be deemed to have voting, investment and dispositive power with respect to these securities"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13G regulatory

"This joint statement on is being filed by Longitude Capital Partners V, LLC"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

Section 13(d)(3) of the Exchange Act regulatory

"may be deemed to be members of a group within the meaning of Section 13(d)(3) of the Exchange Act"

pecuniary interest financial

"disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest"

shared voting power financial

"Shared Voting Power 7,843,138.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 08:18 PM Accepted by SEC EDGAR 08/04/2026 - 08:17 PM Learn about SEC filing dates

FAQ

How much of Entera Bio Ltd. (ENTX) do the Longitude entities report owning?

The Longitude entities report 7,843,138 ordinary shares of Entera Bio Ltd., representing 4.6% of the outstanding ordinary shares based on 172,251,411 shares outstanding as of July 28, 2026.

Who is the record holder of the Entera Bio (ENTX) shares reported in this Schedule 13G?

The record holder is Longitude Venture Partners V, L.P. (LVPV), which owns 7,843,138 ordinary shares. Longitude Capital Partners V, LLC, as general partner, and two managing members may be deemed to share voting and dispositive power.

What percentage of Entera Bio (ENTX) does Seven Fleet reportedly beneficially own?

The filing states Seven Fleet may be deemed to beneficially own 7,053,898 ordinary shares, constituting 4.1% of Entera Bio’s outstanding ordinary shares, based on 172,251,411 shares outstanding as of July 28, 2026.

Do the Entera Bio (ENTX) reporting persons claim to be a group under Section 13(d)?

The reporting persons expressly disclaim status as a group for Section 13(d) purposes and also disclaim beneficial ownership of securities beyond their pecuniary interest, except for shares they hold of record.

What voting and dispositive powers are reported for the Entera Bio (ENTX) shares?

Each reporting person reports 0 shares with sole voting or dispositive power and 7,843,138 shares with shared voting and shared dispositive power, all relating to the LVPV-held ordinary shares.

What is the par value and CUSIP of Entera Bio (ENTX) ordinary shares?

Entera Bio’s ordinary shares have a par value of NIS 0.0000769 per share and carry the CUSIP M40527109, as identified in the ownership disclosure.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Entera Bio Ltd.

(Name of Issuer)

Ordinary Shares, par value per share NIS 0.0000769

(Title of Class of Securities)

M40527109

(CUSIP Number)

07/28/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): M40527109

1

Names of Reporting Persons

Longitude Capital Partners V, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,843,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,843,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,843,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: All such shares are held of record by LVPV (as defined in Item 2(a) below). LCPV (as defined in Item 2(a) below) is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 172,251,411 ordinary shares (as defined in Item 2(d) below) outstanding as of July 28, 2026, as provided by the Issuer (as defined in Item 1(a) below) to the Reporting Persons (as defined in Item 2(a) below).

SCHEDULE 13G

CUSIP Number(s): M40527109

1

Names of Reporting Persons

Longitude Venture Partners V, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,843,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,843,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,843,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Based on 172,251,411 ordinary shares outstanding as of July 28, 2026, as provided by the Issuer to the Reporting Persons.

SCHEDULE 13G

CUSIP Number(s): M40527109

1

Names of Reporting Persons

Patrick G. Enright

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,843,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,843,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,843,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the securities held by LVPV. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 172,251,411 ordinary shares outstanding as of July 28, 2026, as provided by the Issuer to the Reporting Persons.

SCHEDULE 13G

CUSIP Number(s): M40527109

1

Names of Reporting Persons

Juliet Tammenoms Bakker

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,843,138.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,843,138.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,843,138.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: All such shares are held of record by LVPV. LCPV is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to the securities held by LVPV. Juliet Tammenoms Bakker and Patrick G. Enright are the managing members of LCPV and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 172,251,411 ordinary shares outstanding as of July 28, 2026, as provided by the Issuer to the Reporting Persons.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Entera Bio Ltd.
(b)	Address of issuer's principal executive offices: KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, ISRAEL, 9112002
Item 2.
(a)	Name of person filing: This joint statement on Schedule 13G is being filed by Longitude Capital Partners V, LLC (LCPV), Longitude Venture Partners V, L.P. (LVPV and together with LCPV, the Reporting Entities) and Patrick G. Enright and Juliet Tammenoms Bakker (together, the Reporting Individuals). The Reporting Entities and the Reporting Individuals are collectively referred to as the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to this Statement as Exhibit 1. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each Reporting Person is 2740 Sand Hill Road, 2nd Floor, Menlo Park, CA 94025.
(c)	Citizenship: LCPV is a limited liability company organized under the laws of the State of Delaware. LVPV is a limited partnership organized under the laws of the State of Delaware. Each of the Reporting Individuals is a citizen of the United States of America.
(d)	Title of class of securities: Ordinary Shares, par value per share NIS 0.0000769
(e)	CUSIP Number(s): M40527109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of the cover page for each Reporting Person. LVPV is the record owner of 7,843,138 ordinary shares (the LVPV Shares). As general partner of LVPV, LCPV may be deemed to beneficially own the LVPV Shares. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPV and may be deemed to share voting, investment and dispositive power with respect to the LVPV Shares. Except to the extent of his, hers, or its pecuniary interest therein, each Reporting Person disclaims beneficial ownership of such ordinary shares, except for the shares, if any, such Reporting Person holds of record. Longitude Capital Management Co., LLC (LCM), the investment advisor of LVPV, and Seven Fleet Capital Management LP (together with its affiliates, Seven Fleet) have instituted policies and procedures that may affect the acquisition, holding and disposition of securities held by Seven Fleet. As a result of such policies and procedures, the Reporting Persons and Seven Fleet may be deemed to be members of a group within the meaning of Section 13(d)(3) of the Exchange Act. As of the date hereof, based on information provided by or on behalf of Seven Fleet, Seven Fleet may be deemed to be the beneficial owner of 7,053,898 ordinary shares, constituting 4.1% of the number of outstanding ordinary based on 172,251,411 ordinary shares outstanding as of July 28, 2026, as provided by the Issuer to the Reporting Persons. Notwithstanding such policies and procedures, the Reporting Persons expressly disclaim such group membership and beneficial ownership over any ordinary shares that they may be deemed to beneficially own by reason of such policies and procedures. This Schedule 13G shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purpose.
(b)	Percent of class: See Row 11 of the cover page for each Reporting Person and the corresponding footnotes.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page for each Reporting Person and the corresponding footnotes.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page for each Reporting Person and the corresponding footnotes.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each Reporting Person and the corresponding footnotes.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each Reporting Person and the corresponding footnotes.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Under certain circumstances set forth in the limited partnership agreements of LVPV and the limited liability company agreement of LCPV, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of securities of the Issuer owned by each such entity of which they are a partner or member, as the case may be.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Longitude Capital Partners V, LLC

Signature:	/s/ Cristiana Blauth Oliveira
Name/Title:	Cristiana Blauth Oliveira, Authorized Signatory
Date:	08/04/2026

Longitude Venture Partners V, L.P.

Signature:	/s/ Cristiana Blauth Oliveira
Name/Title:	Cristiana Blauth Oliveira, Authorized Signatory
Date:	08/04/2026

Patrick G. Enright

Signature:	/s/ Cristiana Blauth Oliveira
Name/Title:	Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Date:	08/04/2026

Juliet Tammenoms Bakker

Signature:	/s/ Cristiana Blauth Oliveira
Name/Title:	Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
Date:	08/04/2026

Exhibit Information

Exhibit 1 - Joint Filing Agreement